Plasmablastic lymphoma following transplantation.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3603732)

Published in Proc (Bayl Univ Med Cent) on April 01, 2013

Authors

Michael J Van Vrancken1, Latoya Keglovits, John Krause

Author Affiliations

1: Department of Pathology, Baylor University Medical Center at Dallas.

Articles cited by this

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood (1998) 6.26

Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet (1994) 3.56

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol (2004) 1.97

Malignant neoplasms following bone marrow transplantation. Blood (1996) 1.76

Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood (2000) 1.71

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70

Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant (2003) 1.43

Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol (2002) 1.33

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis (1997) 1.23

Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol (2003) 1.12

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation (2001) 1.08

Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol (2005) 0.97

The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Pathol Lab Med (2007) 0.97

Cutaneous presentation of plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old. Pediatr Dermatol (2010) 0.95

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Am J Surg Pathol (2006) 0.95

Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma. J Oral Pathol Med (2006) 0.91

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. Am J Transplant (2011) 0.91

Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology (2007) 0.90

Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant. Leuk Lymphoma (2008) 0.89

Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant. Pediatr Transplant (2009) 0.82

Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection. Transpl Int (2000) 0.81

Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation. Am J Clin Pathol (2005) 0.81

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry. Transplantation (2012) 0.81

Posttransplant lymphoproliferative disease in liver transplant patients. Curr Infect Dis Rep (2011) 0.80

Numb chin syndrome as the initial presentation of posttransplant lymphoproliferative disorder. Proc (Bayl Univ Med Cent) (2012) 0.77